{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:04:41Z","timestamp":1773659081974,"version":"3.50.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1093\/intimm\/14.5.471","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T23:02:40Z","timestamp":1027724560000},"page":"471-479","source":"Crossref","is-referenced-by-count":18,"title":["Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA\u2010B27\u2010associated reactive arthritis"],"prefix":"10.1093","volume":"14","author":[{"given":"Nicolas","family":"Dulphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Rabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Douay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Flinois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saddek","family":"Laoussadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Charron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,5]]},"reference":[{"key":"key\n\t\t\t\t20170710090440_DXF018C1","doi-asserted-by":"crossref","unstructured":"Schlosstein, L., Terasaki, P. I., Bluestone, R. and Pearson, C. M. 1973. High association of an HL\u2010A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med.288:704.","DOI":"10.1056\/NEJM197304052881403"},{"key":"key\n\t\t\t\t20170710090440_DXF018C2","doi-asserted-by":"crossref","unstructured":"Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. and Sturrock, R. D. 1973. Ankylosing spondylitis and HL\u2010A 27. Lancet i:904.","DOI":"10.1016\/S0140-6736(73)91360-3"},{"key":"key\n\t\t\t\t20170710090440_DXF018C3","doi-asserted-by":"crossref","unstructured":"Madden, D. R., Gorga, J. C., Strominger, J. L. and Wiley, D. C. 1992. The three\u2010dimensional structure of HLA\u2010B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell70:1035.","DOI":"10.1016\/0092-8674(92)90252-8"},{"key":"key\n\t\t\t\t20170710090440_DXF018C4","doi-asserted-by":"crossref","unstructured":"Lopez de Castro, J. A. 1998. The pathogenetic role of HLA\u2010B27 in chronic arthritis. Curr. Opin. Immunol.10:59.","DOI":"10.1016\/S0952-7915(98)80033-2"},{"key":"key\n\t\t\t\t20170710090440_DXF018C5","doi-asserted-by":"crossref","unstructured":"Mear, J. P., Schreiber, K. L., Munz, C., Zhu, X., Stevanovic, S., Rammensee, H. G., Rowland\u2010Jones, S. L. and Colbert, R. A. 1999. Misfolding of HLA\u2010B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol.163:6665.","DOI":"10.4049\/jimmunol.163.12.6665"},{"key":"key\n\t\t\t\t20170710090440_DXF018C6","doi-asserted-by":"crossref","unstructured":"Dulphy, N., Peyrat, M. A., Tieng, V., Douay, C., Rabian, C., Tamouza, R., Laoussadi, S., Berenbaum, F., Chabot, A., Bonneville, M., Charron, D. and Toubert, A. 1999. Common intra\u2010articular T cell expansions in patients with reactive arthritis: identical beta\u2010chain junctional sequences and cytotoxicity toward HLA\u2010B27. J. Immunol.162:3830.","DOI":"10.4049\/jimmunol.162.7.3830"},{"key":"key\n\t\t\t\t20170710090440_DXF018C7","doi-asserted-by":"crossref","unstructured":"Ugrinovic, S., Mertz, A., Wu, P., Braun, J. and Sieper, J. 1997. A single nonamer from the Yersinia 60\u2010kDa heat shock protein is the target of HLA\u2010B27\u2010restricted CTL response in Yersinia\u2010induced reactive arthritis. J. Immunol.159:5715.","DOI":"10.4049\/jimmunol.159.11.5715"},{"key":"key\n\t\t\t\t20170710090440_DXF018C8","doi-asserted-by":"crossref","unstructured":"Duchmann, R., May, E., Ackermann, B., Goergen, B., Meyer zum B\u00fcschenfelde, K. H. and M\u00e4rker\u2010Hermann, E. 1996. HLA\u2010B27\u2010restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self\u2010antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand.J. Immunol.43:101.","DOI":"10.1046\/j.1365-3083.1996.d01-16.x"},{"key":"key\n\t\t\t\t20170710090440_DXF018C9","doi-asserted-by":"crossref","unstructured":"Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol.16:359.","DOI":"10.1146\/annurev.immunol.16.1.359"},{"key":"key\n\t\t\t\t20170710090440_DXF018C10","doi-asserted-by":"crossref","unstructured":"Lopez\u2010Botet, M. and Bellon, T. 1999. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol.11:301.","DOI":"10.1016\/S0952-7915(99)80048-X"},{"key":"key\n\t\t\t\t20170710090440_DXF018C11","doi-asserted-by":"crossref","unstructured":"Raulet, D. H., Vance, R. E. and McMahon, C. W. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol.19:291.","DOI":"10.1146\/annurev.immunol.19.1.291"},{"key":"key\n\t\t\t\t20170710090440_DXF018C12","doi-asserted-by":"crossref","unstructured":"Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L. and Colonna, M. 1994. NK3\u2010specific natural killer cells are selectively inhibited by Bw4\u2010positive HLA alleles with isoleucine 80. J. Exp. Med.180:1235.","DOI":"10.1084\/jem.180.4.1235"},{"key":"key\n\t\t\t\t20170710090440_DXF018C13","doi-asserted-by":"crossref","unstructured":"Luque, I., Solana, R., Galiani, M. D., Gonzalez, R., Garcia, F., Lopez de Castro, J. A. and Pe\u00f1a, J. 1996. Threonine 80 on HLA\u2010B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol.26:1974.","DOI":"10.1002\/eji.1830260845"},{"key":"key\n\t\t\t\t20170710090440_DXF018C14","doi-asserted-by":"crossref","unstructured":"Gumperz, J. E., Barber, L. D., Valiante, N. M., Percival, L., Phillips, J. H., Lanier, L. L. and Parham, P. 1997. Conserved and variable residues within the Bw4 motif of HLA\u2010B make separable contributions to recognition by the NKB1 killer cell\u2010inhibitory receptor. J. Immunol.158:5237.","DOI":"10.4049\/jimmunol.158.11.5237"},{"key":"key\n\t\t\t\t20170710090440_DXF018C15","doi-asserted-by":"crossref","unstructured":"Braud, V. M., Allan, D. S. and McMichael, A. J. 1999. Functions of nonclassical MHC and non\u2010MHC\u2010encoded class I molecules. Curr. Opin. Immunol.11:100.","DOI":"10.1016\/S0952-7915(99)80018-1"},{"key":"key\n\t\t\t\t20170710090440_DXF018C16","doi-asserted-by":"crossref","unstructured":"Samaridis, J. and Colonna, M. 1997. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol.27:660.","DOI":"10.1002\/eji.1830270313"},{"key":"key\n\t\t\t\t20170710090440_DXF018C17","doi-asserted-by":"crossref","unstructured":"Colonna, M., Nakajima, H., Navarro, F. and Lopez\u2010Botet, M. 1999. A novel family of Ig\u2010like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol.66:375.","DOI":"10.1002\/jlb.66.3.375"},{"key":"key\n\t\t\t\t20170710090440_DXF018C18","doi-asserted-by":"crossref","unstructured":"Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E. and Lopez\u2010Botet, M. 1999. The ILT2 (LIR1) and CD94\/NKG2A NK cell receptors respectively recognize HLA\u2010G1 and HLA\u2010E molecules co\u2010expressed on target cells. Eur. J. Immunol.29:277.","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20170710090440_DXF018C19","doi-asserted-by":"crossref","unstructured":"Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M. and Lopez\u2010Botet, M. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [see Comments]. J. Exp. Med.186:1809.","DOI":"10.1084\/jem.186.11.1809"},{"key":"key\n\t\t\t\t20170710090440_DXF018C20","doi-asserted-by":"crossref","unstructured":"Bernard, K., Cambiaggi, A., Guia, S., Bertucci, F., Granjeaud, S., Tagett, R., N\u2018Guyen, C., Jordan, B. R. and Vivier, E. 1999. Engagement of natural cytotoxicity programs regulates AP\u20101 expression in the NKL human NK cell line. J. Immunol.162:4062.","DOI":"10.4049\/jimmunol.162.7.4062"},{"key":"key\n\t\t\t\t20170710090440_DXF018C21","doi-asserted-by":"crossref","unstructured":"Mingari, M. C., Schiavetti, F., Ponte, M., Vitale, C., Maggi, E., Romagnani, S., Demarest, J., Pantaleo, G., Fauci, A. S. and Moretta, L. 1996. Human CD8+ T lymphocyte subsets that express HLA class I\u2010specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl Acad. Sci. USA93:12433.","DOI":"10.1073\/pnas.93.22.12433"},{"key":"key\n\t\t\t\t20170710090440_DXF018C22","doi-asserted-by":"crossref","unstructured":"Ugolini, S., Arpin, C., Anfossi, N., Walzer, T., Cambiaggi, A., Forster, R., Lipp, M., Toes, R. E., Melief, C. J., Marvel, J. and Vivier, E. 2001. Involvement of inhibitory NKRs in the survival of a subset of memory\u2010phenotype CD8+ T cells. Nat. Immunol.2:430.","DOI":"10.1038\/85246"},{"key":"key\n\t\t\t\t20170710090440_DXF018C23","doi-asserted-by":"crossref","unstructured":"Vely, F., Peyrat, M., Couedel, C., Morcet, J., Halary, F., Davodeau, F., Romagne, F., Scotet, E., Saulquin, X., Houssaint, E., Schleinitz, N., Moretta, A., Vivier, E. and Bonneville, M. 2001. Regulation of inhibitory and activating killer cell Ig\u2010like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol.166:2487.","DOI":"10.4049\/jimmunol.166.4.2487"},{"key":"key\n\t\t\t\t20170710090440_DXF018C24","doi-asserted-by":"crossref","unstructured":"Uhrberg, M., Valiante, N. M., Young, N. T., Lanier, L. L., Phillips, J. H. and Parham, P. 2001. The repertoire of killer cell Ig\u2010like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig\u2010like receptor patterns. J. Immunol.166:3923.","DOI":"10.4049\/jimmunol.166.6.3923"},{"key":"key\n\t\t\t\t20170710090440_DXF018C25","doi-asserted-by":"crossref","unstructured":"Becker, J. C., Vetter, C. S., Schrama, D., Brocker, E. B. and thor Straten, P. 2000. Differential expression of CD28 and CD94\/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node. Eur. J. Immunol.30:3699.","DOI":"10.1002\/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2"},{"key":"key\n\t\t\t\t20170710090440_DXF018C26","doi-asserted-by":"crossref","unstructured":"Warrington, K. J., Takemura, S., Goronzy, J. J. and Weyand, C. M. 2001. CD4+,CD28\u2013 T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. ArthritisRheum.44:13.","DOI":"10.1002\/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6"},{"key":"key\n\t\t\t\t20170710090440_DXF018C27","doi-asserted-by":"crossref","unstructured":"Namekawa, T., Snyder, M. R., Yen, J. H., Goehring, B. E., Leibson, P. J., Weyand, C. M. and Goronzy, J. J. 2000. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol.165:1138.","DOI":"10.4049\/jimmunol.165.2.1138"},{"key":"key\n\t\t\t\t20170710090440_DXF018C28","doi-asserted-by":"crossref","unstructured":"Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Liennert\u2010Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L. and Parham, P. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity7:753.","DOI":"10.1016\/S1074-7613(00)80394-5"},{"key":"key\n\t\t\t\t20170710090440_DXF018C29","doi-asserted-by":"crossref","unstructured":"Bellon, T., Heredia, A. B., Llano, M., Minguela, A., Rodriguez, A., Lopez\u2010Botet, M. and Aparicio, P. 1999. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94\/kp39 heterodimer. J. Immunol.162:3996.","DOI":"10.4049\/jimmunol.162.7.3996"},{"key":"key\n\t\t\t\t20170710090440_DXF018C30","doi-asserted-by":"crossref","unstructured":"Winter, C. C. and Long, E. O. 1997. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA\u2010C allotypes. J. Immunol.158:4026.","DOI":"10.4049\/jimmunol.158.9.4026"},{"key":"key\n\t\t\t\t20170710090440_DXF018C31","doi-asserted-by":"crossref","unstructured":"Lanier, L. L., Gumperz, J. E., Parham, P., Melero, I., Lopez\u2010Botet, M. and Phillips, J. H. 1995. The NKB1 and HP\u20103E4 NK cell receptor are structurally distinct glycoproteins and independently recognize polymorphic HLA\u2010B and HLA\u2010C molecules. J. Immunol.154:3320.","DOI":"10.4049\/jimmunol.154.7.3320"},{"key":"key\n\t\t\t\t20170710090440_DXF018C32","doi-asserted-by":"crossref","unstructured":"Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H. 1996. Human natural killer cell receptors involved in MHC class I recognition are disulfide\u2010linked heterodimers of CD94 and NKG2 subunits. J. Immunol.157:4741.","DOI":"10.4049\/jimmunol.157.11.4741"},{"key":"key\n\t\t\t\t20170710090440_DXF018C33","doi-asserted-by":"crossref","unstructured":"Braud, V. M., Allan, D. S., O\u2019Callaghan, C. A., Soderstrom, K., D\u2019Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J. 1998. HLA\u2010E binds to natural killer cell receptors CD94\/NKG2A, B and C. Nature391:795.","DOI":"10.1038\/35869"},{"key":"key\n\t\t\t\t20170710090440_DXF018C34","doi-asserted-by":"crossref","unstructured":"Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L. and Phillips, J. H. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science285:730.","DOI":"10.1073\/pnas.96.17.9792"},{"key":"key\n\t\t\t\t20170710090440_DXF018C35","doi-asserted-by":"crossref","unstructured":"Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H. 1998. Association of DAP12 with activating CD94\/NKG2C NK cell receptors. Immunity8:693.","DOI":"10.1016\/S1074-7613(00)80574-9"},{"key":"key\n\t\t\t\t20170710090440_DXF018C36","unstructured":"Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. and Spies, T. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress\u2010inducible MICA. Science285:727."},{"key":"key\n\t\t\t\t20170710090440_DXF018C37","doi-asserted-by":"crossref","unstructured":"De Maria, A., Ferraris, A., Guastella, M., Pilia, S., Cantoni, C., Polero, L., Mingari, M. C., Bassetti, D., Fauci, A. S. and Moretta, L. 1997. Expression of HLA class I\u2010specific inhibitory natural killer cell receptors in HIV\u2010specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl Acad. Sci. USA94:10285.","DOI":"10.1073\/pnas.94.19.10285"},{"key":"key\n\t\t\t\t20170710090440_DXF018C38","doi-asserted-by":"crossref","unstructured":"Galiani, M. D., Aguado, E., Tarazona, R., Romero, P., Molina, I., Santamaria, M., Solana, R. and Pena, J. 1999. Expression of killer inhibitory receptors on cytotoxic cells from HIV\u20101\u2010infected individuals. Clin. Exp. Immunol.115:472.","DOI":"10.1046\/j.1365-2249.1999.00833.x"},{"key":"key\n\t\t\t\t20170710090440_DXF018C39","doi-asserted-by":"crossref","unstructured":"Ikeda, H., Lethe, B., Lehmann, F., van Baren, N., Baurain, J. F., de Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity6:199.","DOI":"10.1016\/S1074-7613(00)80426-4"},{"key":"key\n\t\t\t\t20170710090440_DXF018C40","doi-asserted-by":"crossref","unstructured":"Speiser, D. E., Valmori, D., Rimoldi, D., Pittet, M. J., Lienard, D., Cerundolo, V., MacDonald, H. R., Cerottini, J. C. and Romero, P. 1999. CD28\u2010negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur. J. Immunol.29:1990.","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9"},{"key":"key\n\t\t\t\t20170710090440_DXF018C41","doi-asserted-by":"crossref","unstructured":"Jabri, B., de Serre, N. P., Cellier, C., Evans, K., Gache, C., Carvalho, C., Mougenot, J. F., Allez, M., Jian, R., Desreumaux, P., Colombel, J. F., Matuchansky, C., Cugnenc, H., Lopez\u2010Botet, M., Vivier, E., Moretta, A., Roberts, A. I., Ebert, E. C., Guy\u2010Grand, D., Brousse, N., Schmitz, J. and Cerf\u2010Bensussan, N. 2000. Selective expansion of intraepithelial lymphocytes expressing the HLA\u2010E\u2010specific natural killer receptor CD94 in celiac disease. Gastroenterology118:867.","DOI":"10.1016\/S0016-5085(00)70173-9"},{"key":"key\n\t\t\t\t20170710090440_DXF018C42","doi-asserted-by":"crossref","unstructured":"Benlagha, K., Weiss, A., Beavis, A., Teyton, L. and Bendelac, A. 2000. In vivo identification of glycolipid antigen\u2010specific T cells using fluorescent CD1d tetramers. J. Exp. Med.191:1895.","DOI":"10.1084\/jem.191.11.1895"},{"key":"key\n\t\t\t\t20170710090440_DXF018C43","doi-asserted-by":"crossref","unstructured":"Allen, R. L., Raine, T., Haude, A., Trowsdale, J. and Wilson, M. J. 2001. Cutting edge: leukocyte receptor complex\u2010encoded immunomodulatory receptors show differing specificity for alternative HLA\u2010B27 structures. J. Immunol.167:5543.","DOI":"10.4049\/jimmunol.167.10.5543"},{"key":"key\n\t\t\t\t20170710090440_DXF018C44","doi-asserted-by":"crossref","unstructured":"Boisgerault, F., Mounier, J., Tieng, V., Stolzenberg, M. C., Khalil\u2010Daher, I., Schmid, M., Sansonetti, P., Charron, D. and Toubert, A. 1998. Alteration of HLA\u2010B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri. Infect. Immun.66:4484.","DOI":"10.1128\/.66.9.4484-4490.1998"},{"key":"key\n\t\t\t\t20170710090440_DXF018C45","doi-asserted-by":"crossref","unstructured":"Urban, R. G., Chicz, R. M., Lane, W. S., Strominger, J. L., Rehm, A., Kenter, M. J., UytdeHaag, F. G., Ploegh, H., Uchanska\u2010Ziegler, B. and Ziegler, A. 1994. A subset of HLA\u2010B27 molecules contains peptides much longer than nonamers. Proc. Natl Acad. Sci. USA91:1534.","DOI":"10.1073\/pnas.91.4.1534"},{"key":"key\n\t\t\t\t20170710090440_DXF018C46","doi-asserted-by":"crossref","unstructured":"Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E. 1998. HLA\u2010E surface expression depends on binding of TAP\u2010dependent peptides derived from certain HLA class I signal sequences. J. Immunol.160:4951.","DOI":"10.4049\/jimmunol.160.10.4951"},{"key":"key\n\t\t\t\t20170710090440_DXF018C47","doi-asserted-by":"crossref","unstructured":"Vales\u2010Gomez, M., Reyburn, H. T., Erskine, R. A., Lopez\u2010Botet, M. and Strominger, J. L. 1999. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2\u2010A and the activating receptor CD94\/NKG2\u2010C to HLA\u2010E. EMBO J.18:4250.","DOI":"10.1093\/emboj\/18.15.4250"},{"key":"key\n\t\t\t\t20170710090440_DXF018C48","unstructured":"Brooks, A. G., Borrego, F., Posch, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M., Weiss, E. H. and Coligan, J. E. 1999. Specific recognition of HLA\u2010E, but not classical, HLA class I molecules by soluble CD94\/NKG2A and NK cells. J. Immunol.162:305."},{"key":"key\n\t\t\t\t20170710090440_DXF018C49","doi-asserted-by":"crossref","unstructured":"Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J. P. and Taurog, J. D. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA\u2010B27 and human beta 2m: an animal model of HLA\u2010B27\u2010associated human disorders. Cell63:1099.","DOI":"10.1016\/0092-8674(90)90512-D"},{"key":"key\n\t\t\t\t20170710090440_DXF018C50","doi-asserted-by":"crossref","unstructured":"Khare, S. D., Bull, M. J., Hanson, J., Luthra, H. S. and David, C. S. 1998. Spontaneous inflammatory disease in HLA\u2010B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27\u2010derived peptides. J. Immunol.160:101.","DOI":"10.4049\/jimmunol.160.1.101"},{"key":"key\n\t\t\t\t20170710090440_DXF018C51","doi-asserted-by":"crossref","unstructured":"Lo, W. F., Woods, A. S., DeCloux, A., Cotter, R. J., Metcalf, E. S. and Soloski, M. J. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram\u2010negative pathogens. Nat. Med.6:215.","DOI":"10.1038\/72329"},{"key":"key\n\t\t\t\t20170710090440_DXF018C52","doi-asserted-by":"crossref","unstructured":"Mingari, M. C., Moretta, A. and Moretta, L. 1998. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T cell responses. Immunol. Today19:153.","DOI":"10.1016\/S0167-5699(97)01236-X"},{"key":"key\n\t\t\t\t20170710090440_DXF018C53","doi-asserted-by":"crossref","unstructured":"Mingari, M. C., Ponte, M., Bertone, S., Schiavetti, F., Vitale, C., Bellomo, R., Moretta, A. and Moretta, L. 1998. HLA class I\u2010specific inhibitory receptors in human T lymphocytes: interleukin 15\u2010induced expression of CD94\/NKG2A in superantigen\u2010 or alloantigen\u2010activated CD8+ T cells. Proc. Natl Acad. Sci. USA95:1172.","DOI":"10.1073\/pnas.95.3.1172"},{"key":"key\n\t\t\t\t20170710090440_DXF018C54","doi-asserted-by":"crossref","unstructured":"Waldmann, T. A. and Tagaya, Y. 1999. The multifaceted regulation of interleukin\u201015 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol.17:19.","DOI":"10.1146\/annurev.immunol.17.1.19"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/14\/5\/471\/18321906\/140471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T05:12:50Z","timestamp":1682226770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article-lookup\/doi\/10.1093\/intimm\/14.5.471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,5]]},"published-print":{"date-parts":[[2002,5]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/14.5.471","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}